The goal of this study is to examine the effectiveness and feasibility of a mifepristone-misoprostol medical abortion regimen in terminating pregnancies 13-22 weeks in Burkina Faso.
Study Type
INTERVENTIONAL
Allocation
NA
Purpose
TREATMENT
Masking
NONE
Enrollment
100
Medication used in conjunction with misoprostol for abortion
Medication used in conjunction with mifepristone for abortion
CHUSS
Bobo-Dioulasso, Burkina Faso
RECRUITINGCMA Boromo
Boromo, Burkina Faso
RECRUITINGCHUYO
Ouagadougou, Burkina Faso
RECRUITINGRate of successful abortion
Rate of successful abortion, complete evacuation of foetus and placenta with study drugs, within 24 hours of taking misoprostol
Time frame: 24 hours
This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.
CHR Ouahigouya
Ouahigouya, Burkina Faso
RECRUITING